Ticagrelor Monotherapy
Showing 1 - 25 of 3,850
Intracranial Aneurysm, Stent Complication Trial (Ticagrelor monotherapy, Dual Antiplatelet Therapy)
Not yet recruiting
- Intracranial Aneurysm
- Stent Complication
- Ticagrelor monotherapy
- Dual Antiplatelet Therapy
- (no location specified)
Aug 23, 2023
ST Elevation Myocardial Infarction Trial in Netherlands (Ticagrelor, Aspirin)
Recruiting
- ST Elevation Myocardial Infarction
-
Alkmaar, Netherlands
- +4 more
Aug 3, 2023
Acute Myocardial Infarction Trial in Gothenburg (Ticagrelor 90mg)
Recruiting
- Acute Myocardial Infarction
- Ticagrelor 90mg
-
Gothenburg, SwedenKardiologen
Jun 7, 2022
Antiplatelet Drug, Acute Coronary Syndrome, Angioplasty, Balloon Trial in Xi'an (Aspirin 100mg for 1-month (immediately after
Recruiting
- Antiplatelet Drug
- +2 more
- Aspirin 100mg for 1-month (immediately after PCI)
- +4 more
-
Xi'an, Shannxi, ChinaLing Tao
Jul 20, 2022
Acute Coronary Syndrome, Percutaneous Coronary Intervention Trial in Hangzhou (Standard-DAPT of Ticagrelor plus aspirin,
Not yet recruiting
- Acute Coronary Syndrome
- Percutaneous Coronary Intervention
- Standard-DAPT of Ticagrelor plus aspirin
- Sequential monotherapy of Ticagrelor and clopidogrel
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
Sep 20, 2022
Diabetes, Type 2, Coronary Artery Disease Trial in Jacksonville (Ticagrelor monotherapy, Ticagrelor plus aspirin, Clopidogrel
Recruiting
- Diabetes Mellitus, Type 2
- Coronary Artery Disease
- Ticagrelor monotherapy
- +2 more
-
Jacksonville, FloridaUniversity of Florida
May 31, 2022
Acute Coronary Syndrome Trial in São Paulo (Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid
Recruiting
- Acute Coronary Syndrome
- Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid + prasugrel
- Monotherapy: Ticagrelor alone OR Prasugrel alone
-
São Paulo, BrazilHospital Israelita Albert Einstein
Mar 2, 2023
Coronary Artery Disease, Myocardial Infarction Trial in Ottawa (Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81
Suspended
- Coronary Artery Disease
- Myocardial Infarction
- Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81 mg + Ticagrelor 60mg twice daily
- +2 more
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Feb 17, 2022
Coronary Artery Disease Trial in Jacksonville (aspirin plus clopidogrel, prasugrel or ticagrelor)
Not yet recruiting
- Coronary Artery Disease
- aspirin plus clopidogrel
- prasugrel or ticagrelor
-
Jacksonville, FloridaUniversity of Florida
Jan 4, 2023
Coronary Artery Disease, Platelet Reactivity Trial (CYP2C19 genotype guided P2Y12 monotherapy, Clopidogrel)
Not yet recruiting
- Coronary Artery Disease
- Platelet Reactivity
- CYP2C19 genotype guided P2Y12 monotherapy
- Clopidogrel
- (no location specified)
Mar 7, 2023
Coronary Artery Disease Trial (HT Supreme)
Not yet recruiting
- Coronary Artery Disease
- HT Supreme
- (no location specified)
Aug 16, 2021
Coronary Artery Disease, Acute Coronary Syndrome Trial in Seoul (Standard DAPT, Very-short DAPT less than 1 month after PCI)
Recruiting
- Coronary Artery Disease, Acute Coronary Syndrome
- Standard DAPT
- Very-short DAPT less than 1 month after PCI
-
Seoul, Korea, Republic ofYonsei Cardiovascular Center and Cardiovascular Research Institu
Sep 28, 2020
ST Elevation Myocardial Infarction Trial in Busan (ticagrelor monotherapy, Aspirin with P2Y12 receptor inhibitor)
Unknown status
- ST Elevation Myocardial Infarction
- ticagrelor monotherapy
- Aspirin with P2Y12 receptor inhibitor
-
Busan, Korea, Republic ofDepartment of Internal Medicine,Dong-A University College of Med
Dec 18, 2020
Acute Coronary Syndrome Patients With Diabetes After PCI Trial in Shanghai (Ticagrelor, Aspirin)
Recruiting
- Acute Coronary Syndrome Patients With Diabetes After PCI
-
Shanghai, Chinashanghai Tongren hospital
Aug 31, 2022
Peripheral Artery Disease, Type 2 Diabetes Trial in New York (Aspirin, Ticagrelor, Aspirin Placebo)
Completed
- Peripheral Artery Disease
- Type 2 Diabetes
- Aspirin
- +3 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Mar 18, 2022
Non ST Segment Elevation Acute Coronary Syndrome Trial in Amsterdam (Prasugrel 10mg, Ticagrelor 90mg)
Active, not recruiting
- Non ST Segment Elevation Acute Coronary Syndrome
- Prasugrel 10mg
- Ticagrelor 90mg
-
Amsterdam, NetherlandsAmsterdam UMC, location AMC
Mar 21, 2022
Coronary Artery Disease (CAD) Trial in Worldwide (Ticagrelor, Acetylsalicylic Acid, Clopidogrel)
Completed
- Coronary Artery Disease (CAD)
- Ticagrelor
- +2 more
-
Brisbane, Australia
- +129 more
Mar 13, 2022
Acute Coronary Syndrome Trial (Drug-coated stent, Drug-eluting stent)
Not yet recruiting
- Acute Coronary Syndrome
- Drug-coated stent
- Drug-eluting stent
- (no location specified)
Apr 7, 2022
Bleeding Complications Trial in Rochester (Clopidogrel, Prasugrel, Tricagrelor)
Active, not recruiting
- Bleeding Complications
- Clopidogrel
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 31, 2022
Cerebrovascular Accident, Cerebrovascular Accident, Acute Trial in Beijing (ticagrelor + ASA, Placebo+ASA)
Completed
- Cerebrovascular Accident
- Cerebrovascular Accident, Acute
- ticagrelor + ASA
- Placebo+ASA
-
Beijing, ChinaPeking University Third Hospital
Jul 4, 2021
Chronic Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome Trial in Ireland, Japan (prasugrel Monotherapy)
Recruiting
- Chronic Coronary Syndrome
- Non ST Segment Elevation Acute Coronary Syndrome
- prasugrel Monotherapy
-
Galway, Ireland
- +12 more
Nov 1, 2022
Coronary Artery Disease Trial in Seoul (Clopidogrel monotherapy, Tailored anti-platelet therapy)
Not yet recruiting
- Coronary Artery Disease
- Clopidogrel monotherapy
- Tailored anti-platelet therapy
-
Seoul, Korea, Republic ofSeverance Hospital
Jul 3, 2023
Ischemic Stroke Trial in Kafr Ash Shaykh (Ticagrelor 90 MG, Clopidogrel)
Recruiting
- Ischemic Stroke
- Ticagrelor 90 MG
- Clopidogrel
-
Kafr Ash Shaykh, EgyptKafr Elsheikh University Hospital
Nov 7, 2023
Platelet Reactivity Trial in Harbin (Ticagrelor 90mg, Clopidogrel 75mg)
Completed
- Platelet Reactivity
- Ticagrelor 90mg
- Clopidogrel 75mg
-
Harbin, Heilongjiang, ChinaThrombelastogram
Dec 20, 2021
Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation Trial in Worldwide (P2Y12 inhibitor,
Not yet recruiting
- Percutaneous Coronary Intervention (PCI)
- +3 more
- P2Y12 inhibitor
- +2 more
-
Hasselt, Belgium
- +13 more
Jul 25, 2023